SCHEMBL5899796

SCHEMBL5899796

NCC1(C(=O)O)CC1C1CCCCCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
TSHR P16473 1/20 0.36
BLM P54132 1/20 0.36
CACNA2D1 P54289 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD11B1 P28845 3/20 0.34
GRM2 Q14416 3/20 0.33
GRM1 Q13255 2/20 0.33
CYP2D6 P10635 1/20 0.33
ARG1 P05089 1/20 0.31
SLC1A3 P43003 2/20 0.30
SLC1A2 P43004 2/20 0.30
SLC1A1 P43005 2/20 0.30
GRM6 O15303 1/20 0.30
GRM5 P41594 1/20 0.30
GRM3 Q14832 1/20 0.30
GRM4 Q14833 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899790 1.00 ALDH1A1 (0.36) ALDH1A1USP2LMNACYP1A2TSHR
SCHEMBL5899763 0.98 GRM1 (0.33) ALDH1A1USP2LMNACYP1A2TSHR
SCHEMBL5899776 0.94 ARG1 (0.34) ALDH1A1USP2LMNACYP1A2TSHR
SCHEMBL5899620 0.90 GRM1 (0.39) ALDH1A1USP2LMNACYP1A2TSHR
SCHEMBL5899806 0.71 CYP2D6 (0.38) ALDH1A1USP2LMNACYP1A2TSHR
SCHEMBL5390449 0.70 ALDH1A1 (0.58) ALDH1A1USP2LMNACYP1A2TSHR
SCHEMBL7069827 0.70 HSD11B1 (0.33) HSD11B1
SCHEMBL5899745 0.70 SLC1A3 (0.37) GRM2CYP2D6ARG1SLC1A3SLC1A2
SCHEMBL28666052 0.69 CYP2C19 (0.33) HSD11B1
SCHEMBL5384976 0.68 CYP1A2 (0.55) ALDH1A1USP2LMNACYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030267-B2 Cycloproply β-amino acid derivatives WARNER-LAMBERT COMPANY, LLC (US) 2006-04-18 US claimed
EP-1592661-A2 CYCLOPROPYL BETA-AMINO ACID DERIVATIVES Warner-Lambert Company LLC (US) 2005-11-09 EP claimed
WO-2004065361-A2 CYCLOPROPYL BETA-AMINO ACID DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2004-08-05 WO claimed
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives SCHWARZ JACOB BRADLEY (US) 2004-07-29 US claimed
US-7030267-B2 Cycloproply β-amino acid derivatives WARNER-LAMBERT COMPANY, LLC (US) 2006-04-18 US disclosed
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives SCHWARZ JACOB BRADLEY (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147608-A1 Cyclopropyl beta-amino acid derivatives CACNA1S, CACNA1D, CACNA1B ALDH1A1 1295/4885USP2 3632/4885LMNA 3359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.